This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Acute Effect of Continuous Positive Airway Pressure in Heart Failure

Sponsored by UPECLIN HC FM Botucatu Unesp

About this trial

Last updated 10 years ago

Study ID

upeclin/HC/FMB-Unesp-30

Status

Completed

Type

Interventional

Phase

Phase 2

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 15 years ago

What is this trial about?

Acute effects of CPAP on diastolic function in patients with compensated heart failure (CHF) are unknown. The investigators hypothesized that acutely CPAP improves diastolic function, which is associated with increases exercise tolerance. Objective: To evaluate the acute effects of CPAP on functional capacity and diastolic indices of patients with CHF. This is a randomized trial including 44 patients with compensated heart failure (functional classes II or III, NYHA). Patients will be allocated in CPAP(CPAP with 10cmH2O) or simulated CPAP (null pressure) after computed randomization, in a 1:1 ratio. All subjects shall complete a 6-minute walk test (6MWT) before and after CPAP (30 minutes; 10 cm H2O pressure). Doppler-echocardiogram will be performed before and at the end of CPAP. Wilcoxon or paired t tests were used to compare results, with significance level at p < 0.05.

What are the participation requirements?

Yes

Inclusion Criteria

- functional class II or III (NYHA)heart failure

- agreement to participate in the study

- absence of acute exacerbation of dyspnea

- intact upper airway

No

Exclusion Criteria

- valvular heart disease

- chest pain or unstable angina

- acute myocardial infarction in the prior month

- uncontrolled hypertension

- atrial fibrillation or other arrhythmias

- acute infection

- orthopedic limitations

- intolerance to CPAP mask